Changzhou Smart-Lifesciences Biotechnology Co.,Ltd.

At the meeting, Mr. Fang introduced the development history, corporate culture, R&D strength of Smart-Lifesciences Biotechnology and the breakthrough progress made in the current COVID-19 epidemic. Mr. Fang said that Smart-Lifesciences Biotechnology had fully investigated the market situation of the domestic biological microsphere industry in the early stage. The industry is mainly monopolized by foreign companies. Only by insisting on innovative development can we break the difficulties and open up the road to localization. Therefore, Smart-Lifesciences Biotechnology has continuously increased its investment in research and development, gradually mastered key underlying core technologies, focused on creating high-quality products under a strict quality management system, and strived to create a benchmark for the domestic biological microsphere industry. Products are the core. While carefully developing, Smart-Lifesciences Biotechnology has also created an efficient and mature product management system based on the market to quickly respond to market demand.

During the investigation, General Manager Fang led the investigation team to visit important departments such as the production workshop and R&D laboratory, and introduced the company's R&D technology and future development direction to the investigation team. The leaders showed great interest in Smart-Lifesciences's R&D innovation and related technologies and were full of expectations for Smart-Lifesciences's future development.

Yun Qicheng, deputy secretary of the district party committee and district mayor, emphasized that if you want to achieve great heights, you must have a rich foundation; if you want to flourish, you must have deep roots. Enterprises should focus on deepening the reform of the science and technology system, mobilize all kinds of innovative resources to the maximum extent, and promote more scientific and technological achievements to lead the way while ensuring that epidemic prevention and control measures are in place.

With the support and drive of various national innovation and development policies, Changzhou Smart-Lifesciences Biotechnology has always adhered to the requirements of high-quality development, increased investment in research and development and talents, and continuously improved the core competitiveness of the enterprise, contributing to accelerating the industrialization of biomedical research and biotechnology in my country and establishing a Chinese brand of biological reagents!